Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs

References

• KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol20021206701713 discussion 829–83012049574
   PubMed Web of Science ®Google Scholar
• LichterPRMuschDCGillespieBWCIGTS Study GroupInterim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgeryOphthalmology2001108111943195311713061
   PubMed Web of Science ®Google Scholar
• [No authors listed]The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS InvestigatorsAm J Ophthalmol2000130442944011024415
   PubMed Web of Science ®Google Scholar
• KonstasAGMaskalerisGGratsonidisSSardelliCCompliance and viewpoint of glaucoma patients in GreeceEye (Lond)200014Pt 575275611116698
   PubMed Web of Science ®Google Scholar
• YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm200915972874019954264
   PubMed Web of Science ®Google Scholar
• FriedmanDSQuigleyHAGelbLUsing pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS)Invest Ophthalmol Vis Sci200748115052505717962457
   PubMed Web of Science ®Google Scholar
• SchmierJKCovertDWRobinALFirst-year treatment patterns among new initiators of topical prostaglandin analogsCurr Med Res Opin200925485185819231912
   PubMed Web of Science ®Google Scholar
• SchmierJKCovertDWRobinALFirst-year treatment costs among new initiators of topical prostaglandin analogsClin Ophthalmol2009363764419997567
   PubMedGoogle Scholar
• SchmierJKCovertDWRobinALFirst-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008Curr Med Res Opin201026122769277721043550
   PubMed Web of Science ®Google Scholar
• SchmierJKLauECCovertDWTwo-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogsClin Ophthalmol201041137114320957061
   PubMedGoogle Scholar
• FriedmanDSHahnSRGelbLDoctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency StudyOphthalmology200811581320132718321582
   PubMed Web of Science ®Google Scholar
• HollóGThelenUTeusMALong-term outcomes of prostaglan-din analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in EuropeJ Ocul Pharmacol Ther201127549349821790326
   PubMed Web of Science ®Google Scholar
• HennessyALKatzJCovertDA video study of drop instillation in both glaucoma and retina patients with visual impairmentAm J Ophthalmol2011152698298821821228
   PubMed Web of Science ®Google Scholar
• HennessyALKatzJCovertDProtzkoCRobinALVideotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field lossOphthalmology2010117122345235220580092
   PubMed Web of Science ®Google Scholar
• StoneJLRobinALNovackGDCovertDWCagleGDAn objective evaluation of eyedrop instillation in patients with glaucomaArch Ophthalmol2009127673273619506189
   PubMedGoogle Scholar
• ValenteCIesterMImpact of glaucoma medication on ocular tissueExpert Rev Ophthalmol201053405412
   Google Scholar
• De Saint JeanMBrignoleFBringuierAFBauchetAFeldmannGBaudouinCEffects of benzalkonium chloride on growth and survival of Chang conjunctival cellsInvest Ophthalmol Vis Sci199940361963010067965
   PubMed Web of Science ®Google Scholar
• PisellaPJFillacierKElenaPPDebbaschCBaudouinCComparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbitsOphthalmic Res20003213810657748
   PubMed Web of Science ®Google Scholar
• National Center of Health StatisticsICD-9-CM Index to Diseases and Injuries Addenda2011
   Google Scholar
• SchmierJKCovertDWLauECMedical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucomaClin Drug Investig20123212835842
   Web of Science ®Google Scholar
• QuarantaLBiagioliERivaIProstaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysisJ Ocul Pharmacol Ther201329438238923231442
   PubMed Web of Science ®Google Scholar
• HoudeMCastillouxAMTingeyDAssalianALeLorierJPrescription of topical antiglaucoma agents for patients with contraindications to beta-blockersCan J Ophthalmol200338646947514620034
   PubMed Web of Science ®Google Scholar
• VinkerSKaisermanIWaitmanDABlackmanSKitaiEPrescription of ocular beta-blockers in patients with obstructive pulmonary disease: does a central electronic medical record make a difference?Clin Drug Investig2006269495500
   Web of Science ®Google Scholar
• ChenYFAveryAJNeilKEJohnsonCDeweyMEStockleyIHIncidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practiceDrug Saf2005281678015649106
   PubMed Web of Science ®Google Scholar
• KaisermanIFendyurAVinkerSTopical beta blockers in asthmatic patients-is it safe?Curr Eye Res200934751752219899964
   PubMed Web of Science ®Google Scholar
• FriedmanDSWolfsRCO’ColmainBJEye Diseases Prevalence Research GroupPrevalence of open-angle glaucoma among adults in the United StatesArch Ophthalmol2004122453253815078671
   PubMedGoogle Scholar
• Preferred Practice Pattern. Primary Open Angle GlaucomaSan Francisco, CAAmerican Academy of Ophthalmology2010 Available from: http://one.aao.org/Assets/56c908e3-a939-45ea-b12b-8fe609f547b0/634965436587800000/primary-open-angle-glaucoma-pdfAccessed May 12, 2014
   Google Scholar
• IskedjianMCovertDWWalkerJHPersistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients: a Canadian population-based analysisPatient20114213314121766903
   PubMedGoogle Scholar
• RobinALNovackGDCovertDWCrockettRSMarcicTSAdherence in glaucoma: objective measurements of once-daily and adjunctive medication useAm J Ophthalmol2007144453354017686450
   PubMed Web of Science ®Google Scholar
• RobinALCovertDDoes adjunctive glaucoma therapy affect adherence to the initial primary therapy?Ophthalmology2005112586386815878067
   PubMed Web of Science ®Google Scholar
• RobinAGroverDSCompliance and adherence in glaucoma managementIndian J Ophthalmol201159SupplS93S9621150041
   PubMed Web of Science ®Google Scholar
• TsaiJCA comprehensive perspective on patient adherence to topical glaucoma therapyOphthalmology200911611 SupplS30S3619837258
   PubMed Web of Science ®Google Scholar
• RobinALNovackGDCovertDWCrockettRSMarcicTSAdherence in glaucoma: objective measurements of once-daily and adjunctive medication useAm J Ophthalmol2007144453354017686450
   PubMed Web of Science ®Google Scholar
• SleathBRobinALCovertDByrdJETudorGSvarstadBPatient-reported behavior and problems in using glaucoma medicationsOphthalmology2006113343143616458967
   PubMed Web of Science ®Google Scholar
• OlthoffCMSchoutenJSvan de BorneBWWebersCANoncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based reviewOphthalmology2005112695396115885795
   PubMed Web of Science ®Google Scholar
• RobinALCovertDDoes adjunctive glaucoma therapy affect adherence to the initial primary therapy?Ophthalmology2005112586386815878067
   PubMed Web of Science ®Google Scholar
• TsaiJCMcClureCARamosSESchlundtDGPichertJWCompliance barriers in glaucoma: a systematic classificationJ Glaucoma200312539339814520147
   PubMed Web of Science ®Google Scholar